Becton Dickinson and Co Dividend 2025

Mis teeb Becton Dickinson and Co?

Becton Dickinson and Co (BD) is an American company specializing in medical devices and accessories. It was founded in 1897 in New Jersey and since then has had a long history as an innovator in the healthcare industry. BD's business model is to manufacture and distribute medical devices and accessories for various applications. The company offers a wide range of products, including syringes, needles, catheters, infusion sets, blood diagnostic products, serum samples, tumor analysis devices, sterilization equipment, and more. BD is also a major provider of medical devices and accessories for diabetes management, including insulin pumps, lancets, test strips, and other products. BD operates in three main segments: Medical Devices, Diagnostics, and Life Sciences. In the Medical Devices segment, BD develops, manufactures, and distributes medical products such as syringes, needles, catheters, implants, and surgical instruments. This segment accounts for the largest portion of revenue, as BD's products are widely used in hospitals and other medical facilities worldwide. In the Diagnostics segment, BD offers products and services for the diagnosis of various diseases, particularly in the field of infectious diseases. Here, the company is a leader in the development of tests and instruments for the detection of HIV, hepatitis B and C, tuberculosis, and other infections. BD's Life Sciences segment produces and distributes devices and reagents for research and development, particularly in the areas of cell analysis, genomics, and proteomics. The company works closely with academics, researchers, and the pharmaceutical industry to develop innovative solutions that can contribute to the discovery of new therapies. BD is known for its long-standing experience in healthcare, its deep industry knowledge, and its efforts to develop new technologies and products that can improve people's lives. BD's products are manufactured and distributed in the United States and in more than 50 countries worldwide. Some of BD's most popular products include insulin pumps, syringes and needles, automated infusion systems, blood testing materials, and tumor diagnosis devices. In recent times, due to the pandemic, BD has also invested heavily in the development of test kits and protective clothing, thereby adapting part of its business model to the COVID-19 crisis. Overall, BD is a leading company in the medical and healthcare industry, characterized by its long history, comprehensive range of medical devices, and innovative power. With a strong focus on quality and customer satisfaction, BD remains an important provider of healthcare products and services in the healthcare industry. Becton Dickinson and Co on üks populaarsemaid ettevõtteid saidil Eulerpool.com.